Lamana M, Fernández-Rañada J M
Servicio de Hematología, Hospital de la Princesa, Diego de León, Madrid.
Sangre (Barc). 1991 Dec;36(6):501-3.
Cyclophosphamide derivatives for in vitro use, such as mafosphamide L lysine (ASTA-Z 7654) are capable of removing residual leukaemic cells from the bone marrow used for autologous transplantation. ASTA-Z also removes committed stem cells detected in semi-solid cultures (CFU-GM). However, haemopoiesis is preserved by more immature progenitors, undetected in usual cultures but detectable in liquid culture of 21 days (MTC). After treating 15 normal bone marrow specimens with 100 microM ASTA-Z, CFU-GM cultures and medium-term cultures (MTC) are carried out. CFU-GM are cultured on the 21st day of incubation from the cell suspension of the MTC. The CFU-GM made the day of in vitro treatment (0.9 colonies/plate) reappear in the CFU-GM cultures performed on the 21st day of incubation of MTC (42 colonies/plate), although the figures attained in parallel controls without any treatment are not fully reached.
用于体外的环磷酰胺衍生物,如马磷酰胺L-赖氨酸(ASTA-Z 7654)能够从用于自体移植的骨髓中清除残留的白血病细胞。ASTA-Z还能清除在半固体培养物(CFU-GM)中检测到的定向干细胞。然而,造血功能由更不成熟的祖细胞维持,这些祖细胞在常规培养物中未被检测到,但在21天的液体培养(MTC)中可被检测到。用100微摩尔ASTA-Z处理15份正常骨髓标本后,进行CFU-GM培养和中期培养(MTC)。CFU-GM在MTC细胞悬液培养的第21天进行培养。尽管未进行任何处理的平行对照所达到的数值未被完全达到,但在MTC培养第21天进行的CFU-GM培养中,体外处理当天产生的CFU-GM(0.9个集落/平板)再次出现(42个集落/平板)。